Betaxolol Hydrochloride

盐酸倍他洛尔

Report date: 2025/07/29 10:44:51
NME

Base Information

Drug NameBetaxolol Hydrochloride
Drug Alias NameBetoptic S倍他索洛尔Betaxololum贝他索洛尔盐酸盐盐酸贝他洛尔 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsHypertensionGlaucoma, Open-Angle +[5] 
Global Approved IndicationsHypertensionGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1985/08/30
Country/TerritoryUnited StatesSwedenMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSA Alcon Couvreur NVSanofi-Synthelabo GroupeSandoz Inc
Inactive CompaniesSanofi-Aventis U.S. LlcNational Eye Institute (Nei)The Smith-Kettlewell Eye Research Institute
Active IndicationsHypertensionGlaucoma, Open-AngleGlaucoma +[4] 
Inactive IndicationsDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeC07AB05S01ED02
Related LinksWikipediaDrugBankKEGG